Home
Coherus Biosciences, Inc.

Coherus Biosciences, Inc. Market Share Analysis for August 2026

Check out job opportunities at Coherus Oncology, a commercial-stage company advancing next-generation combination therapies for people living with cancer.

Health > Biotechnology and Pharmaceuticals

Domaincoherus.com

Year Founded2010

Employees201 - 500

Annual Revenue$200M - $500M

Coherus Biosciences, Inc.

Coherus Biosciences, Inc. (including company regionals)

coherus.com

See more website traffic and engagement information

Coherus Biosciences, Inc. Revenue up to August 2026 is 200M - 500M

revenue generated by Coherus Biosciences, Inc. top domains

Coherus Biosciences, Inc. top domains revenue over 3 years

Revenue for Coherus Biosciences, Inc. top domains

coherus.com200M - 500M

See more with Sales Intelligence

Total visits to Coherus Biosciences, Inc.'s top domains

Understand Coherus Biosciences, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

coherus.com7.7K

See more with Sales Intelligence

Avg. visit duration in Coherus Biosciences, Inc.'s top domains

Analyze Coherus Biosciences, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

coherus.com00:00:49

See more with Sales Intelligence

Avg. pageviews on Coherus Biosciences, Inc.'s top domains

See how Coherus Biosciences, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

coherus.com2.29

See more with Sales Intelligence

Coherus Biosciences, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

amgen.comCompany NameAmgenEmployees> 10001HQUnited States, California, Thousand OaksAnnual revenue> $1BTotal visits757.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Coherus Biosciences, Inc.

These are the website technologies, by industry, used by Coherus Biosciences, Inc. top domains

Advertising (19)

DoubleClick

Conversion & Analytics (9)

Google Analytics

Payment & Currencies (8)

Cart Functionality

Widget (5)

reCAPTCHA

More Technologies

13

See all

News & Signals from Coherus Biosciences, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCoherus BioSciences, Inc. partnered with Zumutor Biologics Inc. on Jun 23rd '26.REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) - Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. ("Zumutor"), an immuno-oncology biotech company, today announced a clinical collaboration and supply agreement to conduct a Phase 1 trial of ZM008, a novel NK checkpoint anti-LLT1 monoclonal antibody in combination with LOQTORZI (toripalimab-tpzi), a next-generation PD-1 inhibitor (Trial ID: NCT06451497).

NewsCoherus BioSciences, Inc. had revenue of $12.8M on Mar 10th '26.On March 10, Coherus Oncology Inc. (NASDAQ:CHRS) reported its fourth quarter EPS of (34c) above the street consensus of (31c), while revenue came in at $12.8 million versus $14.1 million expected.

NewsInovio partnered with Coherus BioSciences, Inc. on Jan 1st '24.On the business development front, Inovio entered a clinical collaboration and supply agreement with Coherus BioSciences in January 2024 to evaluate INO-3112 in combination with Loqtorzi (toripalimab-tpzi), Coherus's FDA-approved PD-1 inhibitor, in a planned Phase III trial targeting locoregionally advanced HPV16/18-positive oropharyngeal squamous cell carcinoma across North America and Europe.